Dysregulation of miRNA expression in patients with chronic myelogenous leukemia at diagnosis: a systematic review

Conclusion: miRNAs can be used as an indicator for the early detection and treatment of CML phase.PMID:38230979 | DOI:10.2217/bmm-2023-0575

Source: Future Medicine: Biomarkers in Medicine - January 17, 2024 Category: Internal Medicine Authors: Mohammad Parsa-Kondelaji Maryam Musavi Faezeh Barzegar Neda Abbasian Mehrdad Rostami Mohammad R Seyedtaghia Seyyed S Hashemi Mahdiyeh Modi Banafsheh Nikfar Amir A Momtazi-Borojeni Source Type: research